EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks’ gestation

Or Touval iD, Avital Ellert, Yair Daykan, Ron Schonman, Zvi Klein, Yael Yagur

Archives of Gynecology and Obstetrics · 2024

DOI: 10.1007/s00404-024-07737-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Or Touval und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St, Kfar Saba, Israel. ortouval@gmail.com. Hauptthemen laut MEDLINE: Misoprostol, Mifepristone, Abortion, Induced, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare duration of medication abortion after pretreatment with mifepristone versus misoprostol-only regimens at 22 + 0/7 to 30 + 0/7 weeks.

Methods

This retrospective cohort study included patients admitted for medication abortion from 2014 to 2022. Patients underwent feticide due to genetic or anatomical abnormalities at gestational age of 22 + 0/7 to 30 + 0/7 weeks. Excluded from this study were patients admitted at gestational age < 22 + 0/7 or > 30 + 0/7 weeks, with multiple gestation, with diagnosis of intrauterine fetal demise before feticide, with contraindication for vaginal delivery, and who were administered a medical regimen other than the mifepristone-misoprostol or misoprostol-only protocol. Information collected included patients’ demographics, clinical outcomes, additional procedural interventions, and complications. Data of patients treated with mifepristone-misoprostol versus misoprostol-only were compared.

Results

The study group included 46 patients in the mifepristone-misoprostol group and 35 in the misoprostol-only group. Median interval from first dose of misoprostol to fetal expulsion was shorter in the mifepristone-misoprostol group (10.6 vs. 15.3 h; p = 0.007) with shorter duration of hospitalization (3.5 ± 1.1 vs. 4.1 ± 1.2 days; p = 0.013). Study groups did not differ in terms of complications. Patients in the mifepristone-misoprostol group had a younger gestational age (23.8 ± 1.69 vs. 25.37 ± 2.4 weeks; p = 0.002). However, multivariable Cox regression found that mifepristone was independently associated with shorter abortion time (OR 1.7, 95% CI 1.03–2.9, p = 0.03).

Conclusion

Medication abortion with mifepristone-misoprostol was associated with shorter time to fetal expulsion at gestational ages 22 + 0/7 to 30 + 0/7 weeks, compared with misoprostol-only regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolMifepristoneAbortion, InducedAbortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalAbortifacient AgentsHumansFemalePregnancyRetrospective StudiesAdultGestational AgePregnancy Trimester, SecondTreatment OutcomeDrug Therapy, Combination

Stichwörter der Autor:innen

AbortionMifepristoneMisoprostolTermination of pregnancy

Substanzen

MisoprostolMifepristoneAbortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalAbortifacient Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St, Kfar Saba, Israel. ortouval@gmail.com.
  • Affiliated with the School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. ortouval@gmail.com.
  • Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St, Kfar Saba, Israel.
  • Affiliated with the School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Or Touval

Förderung

  • Tel Aviv University

Zitieren

APA

Touval, O., Ellert, A., Daykan, Y., Schonman, R., Klein, Z., & Yagur, Y. (2024). The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks’ gestation. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07737-2

Vancouver

Touval O, Ellert A, Daykan Y, Schonman R, Klein Z, Yagur Y. The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks’ gestation. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07737-2

BibTeX
@article{Touval2024,
  author = {Touval, Or and Ellert, Avital and Daykan, Yair and Schonman, Ron and Klein, Zvi and Yagur, Yael},
  title = {The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks’ gestation},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  doi = {10.1007/s00404-024-07737-2}
}
Kostenlos starten →